Endothelial targets, such as CD31, CD34 and, increasingly, endoglin, which is also involved in angiogenesis, were used as endothelial targets for MDV calculation in HNSCC (27, 28). This evidence concerns the gene PECAM1 and head and neck squamous cell carcinoma.